vimarsana.com
Home
Live Updates
SkylineDx announces Medicare coverage for its predictive mel
SkylineDx announces Medicare coverage for its predictive mel
SkylineDx announces Medicare coverage for its predictive melanoma assay Merlin Test
ROTTERDAM, Netherlands and SAN DIEGO, May 25, 2022 /PRNewswire/ -- Today, SkylineDx, a leading molecular diagnostics company, announces Medicare coverage for Merlin Test. The local coverage
Related Keywords
Palmetto ,
California ,
United States ,
San Diego ,
Netherlands ,
The Netherlands ,
Kostenloser Wertpapierhandel ,
Dharminder Chahal ,
Molecular Diagnostic Service Program Mol ,
Falcon Rd Program ,
Laboratory Developed Test ,
Merlin Study Initiative ,
Risk Stratification Molecular ,
Medicare Administrative Contractor Palmetto ,
Molecular Diagnostic Service Program ,
Merlin Test ,
Sentinel Lymph Node Biopsy ,
Skylinedx ,
Nnounces ,
Medicare ,
Coverage ,
Predictive ,
Melanoma ,
Essay ,
Berlin ,
Pest ,